OMX30 1 581 1,2%  OMXH25 3 788 0,8%  OMXC20 904 0,9%  Dow 20 718 0,3%  Nas 5 365 -0,1%  EUR 9,5229 0,3%  USD 8,8325 0,4%  Olja 50,5 -0,3%  Guld 1 245 -0,2% 

Amgen Aktie

167,00USD -0,47USD -0,28%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Amgen

2016 2017e 2018e 2019e 2020e
Utdelning 4,00 4,53 4,88 5,28 5,80
Direktavkastning (i %) 2,71 2,65 2,86 3,09 3,39
PE-tal 12,69 13,84 13,44 12,82 12,29
Resultat/aktie 11,65 12,35 12,72 13,34 13,91
ytterligare nyheter

Analyser om Amgen Inc.

ytterligare analyser

Amgen Peer Group

Agennix 0,04
0,0%
Amgen 167,00
-0,3%
BB BIOTECH 54,95
1,1%
Bayer 106,95
1,8%
Biogen 278,46
0,2%
Biotest 19,98
-0,4%
EVOTEC 8,14
0,5%
Gilead Sciences 67,61
-0,3%
MorphoSys 54,00
1,9%
QIAGEN 28,86
0,7%
Sanofi 83,30
0,6%
pagehit

Lägg till instrument

Vad tycker du?

Profil Amgen Inc.

till bolagsprofilen
Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. Its products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Realtidskurs Amgen Inc.

Bid
166,88
USD
Ask
167,00
USD
Kurstid
19:44
Börsen BTT

Aktiekurs Amgen Inc. i USDPUSH CHART

Kurs 167,00 USD -0,47 -0,28 %
Kurstid 19:44:54
Datum 23.03.2017
Öppning 167,49
Gårdagen 167,47
Dagshögsta 167,93
Dagslägsta 166,25
52 v. högsta 184,21
52 v. lägsta 133,26
52 v. perf.
Volym (Antal) 125 959
Börsvärde (SEK) 1 083,62 Mrd
Börsen
Kurs för 167,00 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 475,03 SEK.

Till aktien Amgen

Ticker
ISIN US0311621009
Index NASDAQ 100, S&P 100, NASDAQ Comp., S&P 500, BX Swiss - USA

Amgen Nyckeltal

Börsvärde i SEK 1 083,62 Mrd
Free float % 99,82
Antal aktier mio. 736,45
Cashflow/aktie i lokal valuta 12,53
Bokvärde/aktie i lokal valuta 39,94
60 dagar vola 24,51
PBV 3,70

Amgen Historiska kurser

2017-03-22 167,47 202 899
2017-03-21 166,92 318 183
2017-03-20 169,21 395 729
2017-03-17 168,80 1 424 924
2017-03-16 180,12 302 169

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 578,1 %
Exelixis Inc. 455,9 %
Ariad Pharmaceuticals Inc. 260,2 %
Array BioPharma Inc. 252,2 %
EXACT Sciences Corp. 232,5 %